Supported by

Mitral valve replacement and repair

Latest mitral valve replacement and repair content in interventional cardiology - research, practice, and education

Building on the years of experience with TAVI, mitral valve replacement and repair (TMVR) is now beginning to take-off with a vast array of new techniques and options. Certain devices, for instance in mitral repair, are now widely used. To understand this complex field a knowledge and mastery is required covering the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Mitral valve replacement and repair

633 results

From Guidelines to patients’ lives: how to apply and connect the community

04 Jun 2026

Watch this replay with M. Swaans, P. Lurz, M. Cikes and F. Praz to learn how to differentiate ventricular versus atrial secondary mitral regurgitation phenotypes and much more!

From Guidelines to patients’ lives: how to apply and connect the community

Structural and Valve interventions: EuroPCR 2026 highlights

Christopher Cook hosts Bernard Prendergast and Nicolas Dumonteil as they discuss their standout moments from the structural track at EuroPCR 2026. Together, they reflect on the evolution of structural interventions showcased throughout the Course, moving beyond TAVI to the growing importance of mitral and tricuspid therapies...

Structural and Valvular Interventions: EuroPCR 2026 highlights

The continuum of valvular heart disease: a lifetime management approach

21 May 2026 – From EuroPCR 2026

This session offers a comprehensive perspective on valvular heart disease through the lens of lifetime management, highlighting the need for strategic planning across aortic, mitral, and tricuspid interventions, illustrating how treating one valve can influence the progression and management of others. Gain insights into optimal timing...

The continuum of valvular heart disease: a lifetime management approach

Jon DeHaan Foundation and the Michele Pighi Young Investigator Awards 2026

21 May 2026

At EuroPCR 2026, two awards highlighted innovation and emerging talent in interventional cardiology. Lene Andreasen received the Michele Pighi Young Investigator Award for her research on coronary bifurcation PCI from the OCTOBER trial, while Susheel Kodali and the Nyra Medical team were honoured with the Jon...

Jon DeHaan Foundation Award and the Michele Pighi Young Investigator Award

Jon DeHaan Foundation Award 2026: presentation of the foundation, the winner and his project

21 May 2026 – From EuroPCR 2026

In this exclusive EuroPCR 2026 interview, Jose Calle Gordo, Tom DeHaan, and Susheel Kodali discuss the 2026 Jon DeHaan Foundation Award and the innovation behind this year’s winning project.

Discover how nearly 500 submissions were reviewed to identify the top innovations in interventional cardiology, and learn more...

Inside the Jon DeHaan Foundation Award 2026

Combined mitral intervention and LAA closure: LIVE Educational Case from Rigshospitalet Heart Centre - Copenhagen, Denmark

21 May 2026 – From EuroPCR 2026

This session offers a comprehensive educational experience on combined mitral intervention and LAA closure. It identifies ideal candidates, addresses procedural challenges of performing both interventions in a single session, and provides a detailed, step-by-step guide through a live case from Rigshospitalet Heart Centre.

Challenging transcatheter interventions for mitral stenosis and mitral annular calcification

21 May 2026 – From EuroPCR 2026

This session addresses the challenges of transcatheter interventions in severe mitral stenosis and mitral annular calcification. It highlights therapeutic innovations such as treating mitral stenosis with annular calcification, valve-in-MAC procedures, use of extra-large Myval valves, transatrial ViMAC approaches, and combined multivalve interventions in rheumatic heart disease.

Innovation in transcatheter mitral valve interventions

21 May 2026 – From EuroPCR 2026

This comprehensive session presents the latest innovations in transcatheter mitral valve interventions, highlighting cutting-edge devices and clinical experiences. Topics include early feasibility studies of novel hemivalve systems, first-in-human experiences with new mitral valve replacement technologies, advances in transcatheter edge-to-edge repair (TEER) with one-year outcome data, and...

Percutaneous management of mitral and aortic valve disease

21 May 2026 – From EuroPCR 2026

Delve into the percutaneous management of mitral and aortic valve disease through detailed procedural demonstrations. This session covers valve-in-valve procedures, navigation of potential complications in valve-in-valve TAVI, and mitral valve edge-to-edge repair techniques, supported by real-world case discussions and key learnings.

Mitral interventions: procedural risk assessment and interventions

21 May 2026 – From EuroPCR 2026

Focused on mitral valve interventions, this session covers procedural risk assessment and outcomes following transcatheter edge-to-edge repair (TEER). Topics include predictive risk scores, technical complexity, pulmonary artery pressure indices, right ventricle-pulmonary artery coupling, and novel imaging predictors influencing procedural success and patient prognosis.